Importance of diagnostics in epidemic and pandemic preparedness
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Diagnostics are fundamental for successful outbreak containment. In this supplement, ‘Diagnostic preparedness for WHO Blueprint pathogens’, we describe specific diagnostic challenges presented by selected priority pathogens most likely to cause future epidemics. Some challenges to diagnostic preparedness are common to all outbreak situations, as highlighted by recent outbreaks of Ebola, Zika and yellow fever. In this article, we review these overarching challenges and explore potential solutions. Challenges include fragmented and unreliable funding pathways, limited access to specimens and reagents, inadequate diagnostic testing capacity at both national and community levels of healthcare and lack of incentives for companies to develop and manufacture diagnostics for priority pathogens during non-outbreak periods. Addressing these challenges in an efficient and effective way will require multiple stakeholders—public and private—coordinated in implementing a holistic approach to diagnostics preparedness. All require strengthening of healthcare system diagnostic capacity (including surveillance and education of healthcare workers), establishment of sustainable financing and market strategies and integration of diagnostics with existing mechanisms. Identifying overlaps in diagnostic development needs across different priority pathogens would allow more timely and cost-effective use of resources than a pathogen by pathogen approach; target product profiles for diagnostics should be refined accordingly. We recommend the establishment of a global forum to bring together representatives from all key stakeholders required for the response to develop a coordinated implementation plan. In addition, we should explore if and how existing mechanisms to address challenges to the vaccines sector, such as Coalition for Epidemic Preparedness Innovations and Gavi, could be expanded to cover diagnostics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Severe acute respiratory syndrome
Peiris, J. S. M., Guan, Y., & Yuen, K. Y. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,139
Access to pathology and laboratory medicine services: a crucial gap
Wilson, M. L., Fleming, K. A., Kuti, M. A., Looi, L. M., Lago, N., & Ru, K. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30458-6 · Cited by 444
Gebreyes, W. A., Dupouy-Camet, J., Newport, M. J., Oliveira, C. J. B., Schlesinger, L. S., Saif, Y. M., Kariuki, S., Saif, L. J., Saville, W., Wittum, T., et al. (2014) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003257 · Cited by 400 · cited 1×
“17 A ‘One Health’ approach to surveillance that integrates human, animal and ecological health would provide earlier opportunities for outbreak detection and prevention; however, a number of challenges to implementing such an approach exist, including need for greater cross-sectoral communication, strengthening of lab…”
BackgroundThe Zika Virus Epidemic in Brazil: From Discovery to Future Implications
Lowe, R., Barcellos, C., Brasil, P., Cruz, O., Honório, N., Kuper, H., & Carvalho, M. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010096 · Cited by 398 · cited 1×
“8 The absence of a specific marker for Zika surveillance was largely responsible for the wide spread of the disease, as without surveillance information, effective control measures could not be put in place.(8) The disconnect between surveillance findings and provision of vaccines negatively impacted the containment r…”
The Next Epidemic — Lessons from Ebola
Gates, B. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1502918 · Cited by 288
After Ebola in West Africa — Unpredictable Risks, Preventable Epidemics
WHO Ebola Response Team (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1513109 · Cited by 280 · cited 2×
“Filoviruses (Ebola and Marburg) 24%–90%(40) 41 West Africa, 2013–2016 and DRC 2017 and 2018 (Ebola).(10) Uganda and Kenya, 2017 (Marburg).”
BackgroundSayed, S., Cherniak, W., Lawler, M., Tan, S. Y., El Sadr, W., Wolf, N., Silkensen, S., Brand, N., Looi, L. M., Pai, S. A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30459-8 · Cited by 224 · cited 1×
“22 Additionally, diagnostics that require limited sample preparation would reduce training needs and minimise the risk to laboratory workers, and so would be particularly advantageous for pathogens that are easily transmittable and/or cause severe disease.”
Update on Influenza Diagnostics: Lessons from the Novel H1N1 Influenza A Pandemic
Kumar, S., & Henrickson, K. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05016-11 · Cited by 145 · cited 2×
“32 The influenza example demonstrates the positive impact that collaboration between global and national stakeholders and industry can have on the speed and effectiveness of response.”
BackgroundLaboratory medicine in low-income and middle-income countries: progress and challenges
Nkengasong, J. N., Yao, K., & Onyebujoh, P. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30308-8 · Cited by 141
Self-citationHumoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology
Priyamvada, L., Hudson, W. H., Ahmed, R., & Wrammert, J. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.42 · Cited by 129 · cited 1×
“30 Efforts to validate BMJ Global Health diagnostic tests for the WHO R&D Blueprint pathogens CCHF and MERS-CoV have also been hampered by difficulties with sourcing of clinical specimens, as described elsewhere in this supplement.”
Cited by
Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA
Patchsung, M., Jantarug, K., Pattama, A., Aphicho, K., Suraritdechachai, S., Meesawat, P., Sappakhaw, K., Leelahakorn, N., Ruenkam, T., Wongsatit, T., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00603-x · Cited by 640
Martindale, A.-M., Pilbeam, C., Mableson, H., Tonkin-Crine, S., Atkinson, P., Borek, A., Lant, S., Gobat, N., Solomon, T., & Sheard, S. (2021) · BMC Public Health · doi:10.1186/s12889-021-11285-8 · Cited by 20
Metadata
- Authors
- Kelly-Cirino, C. D., Nkengasong, J., Kettler, H., Tongio, I., Gay-Andrieu, F., Escadafal, C., Piot, P., Peeling, R. W., Gadde, R., & Boehme, C.
- Venue
- BMJ Global Health
- Publisher
- BMJ
- Published
- 2019-01-29
- Volume
- 4
- Issue
- Suppl 2
- Pages
- e001179
- ISSN
- 2059-7908 (ISSN-L)
- OpenAlex
- W2912453786
- Cited by
- 164
- References
- 19
- Type
- conference abstract
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Importance of diagnostics in epidemic and pandemic preparedness. https://app.cochat.ai/papers/10.1136/bmjgh-2018-001179
- The paper
- Kelly-Cirino, C. D., Nkengasong, J., Kettler, H., Tongio, I., Gay-Andrieu, F., Escadafal, C., Piot, P., Peeling, R. W., Gadde, R., & Boehme, C. (2019). Importance of diagnostics in epidemic and pandemic preparedness. BMJ Global Health. https://doi.org/10.1136/bmjgh-2018-001179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.